Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
UK Startups and Innovation
13MAY

Business Bank begins direct startup investment

3 min read
20:05UTC

The British Business Bank can now lead venture rounds and invest up to £60m per company, backed by a £6.6bn mandate. It is the first time the state bank has competed directly with private VCs.

TechnologyDeveloping
Key takeaway

The British Business Bank moves from backing funds to backing companies, up to £60m per deal.

HM Treasury gave the British Business Bank (BBB) an additional £6.6bn mandate to deploy by 2030, with a new power to lead venture rounds and invest directly in startups at up to £60m per company from April 2026 1. A new £4bn Industrial Strategy Growth Capital Initiative targets eight priority sectors including advanced manufacturing, clean energy, defence, and life sciences. Total BBB financial capacity now stands at £25.6bn.

The BBB has historically operated as a fund-of-funds, distributing capital through intermediary managers rather than picking companies. Direct investment at Series B and C scale places government capital in direct competition and collaboration with VC funds. The £60m single-company cap is large enough for meaningful growth rounds; it signals an intent to anchor later-stage deals rather than seed the earliest companies.

The mandate also tasks the BBB with mobilising pension fund and insurance capital into UK growth companies, a structural gap that has left UK founders dependent on foreign investors for large rounds. The BBB's previous track record (£6.3bn in public funding generating an estimated £43bn in gross value added) will be the benchmark against which this expanded role is measured.

Deep Analysis

In plain English

The British Business Bank (BBB) is a government-owned bank that supports small and growing companies. Until now, it mostly invested indirectly, by putting money into private venture capital funds which then invested in startups. From April 2026, it can now invest directly: write a cheque straight to a company for up to £60m. This is a significant change. The government is now a direct participant in the UK startup investment market, writing its own cheques rather than routing money through private funds. Whether that is good or bad depends on whether government-backed capital crowds out or complements private investors.

Deep Analysis
Root Causes

The BBB direct investment mandate addresses a specific structural gap: UK pension and insurance funds are legally permitted but practically constrained from investing in UK venture capital by liability-matching obligations and illiquidity premiums.

The UK Pension Schemes Act 2021's illiquidity disclosure requirements and the FCA's Solvency UK framework (replacing Solvency II) create cost-of-capital advantages for liquid public equities over illiquid VC positions. The BBB is compensating for a regulatory-induced market failure rather than a genuine absence of investable capital.

The £4bn Industrial Strategy Growth Capital Initiative within the BBB mandate is also a response to the concentration of UK VC in London and the South East. Cambridge, Oxford, and London receive approximately 80% of UK venture investment by value. The regional allocation mandate within the BBB's eight priority sectors is intended to address this geographic distortion.

What could happen next?
  • Opportunity

    UK growth-stage companies in eight priority sectors gain access to a new lead investor capable of writing £60m cheques without US VC involvement.

  • Risk

    BBB direct investment at growth stage may reduce private VC pricing discipline and distort valuations in priority sectors, creating zombie-company risk if government capital sustains companies that the market would otherwise price out.

First Reported In

Update #1 · State capital floods in, seed money drains

HM Treasury· 13 Apr 2026
Read original
Different Perspectives
Australian Department of Defence (AUKUS AI for Acoustics partner)
Australian Department of Defence (AUKUS AI for Acoustics partner)
Rowden Technologies holds active AUKUS AI for Acoustics contracts with the UK, US, and Australian defence establishments. The NWF's £25m investment in Rowden on 13 May brings UK sovereign capital directly into a trilateral programme, which from Canberra's perspective places additional UK government skin-in-the-game on a programme Australia co-funds and co-develops.
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova Partners (European VC co-investor in Cytospire Series A)
Sofinnova participated alongside the BBB in Cytospire's oversubscribed £61m Series A on 5 May, demonstrating that the BBB's expanded direct mandate is attracting established European specialist biotech funds rather than replacing them. European VCs see the BBB's cornerstone position as a signal reducing UK biotech execution risk rather than crowding out private capital.
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Temasek (Singapore sovereign co-investor in Isomorphic Series B)
Singapore's Temasek co-invested alongside the UK's SAIU in Isomorphic's $2.1bn round, treating the same Alphabet-majority company as an acceptable sovereign co-investment target. Temasek's participation normalises the structure: multiple sovereign wealth funds backed the same round, strengthening the precedent that UK-headquartered Alphabet subsidiaries qualify for state investment.
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet / Google (majority Isomorphic shareholder, Mountain View)
Alphabet co-invested via GV and CapitalG in the same Isomorphic Series B round that received UK sovereign backing, placing US corporate capital and UK public capital in the same syndicate without any governance asymmetry. SAIU's minority stake validates Isomorphic's strategic value without constraining Alphabet's control over IP, geography, or exit decisions.
DSIT / Liz Kendall, Secretary of State for Science
DSIT / Liz Kendall, Secretary of State for Science
DSIT framed the Isomorphic investment as backing a British-founded and headquartered company advancing UK AI capability, and described the nine-day sovereign deployment sprint as evidence the government's industrial strategy is operational. The department has not addressed the ownership question, the absence of eligibility criteria, or the pace-versus-doctrine tension in the BBB mandate.
Beauhurst / UK startup data analysts
Beauhurst / UK startup data analysts
Five sub-£50m rounds closed in nine days with zero VCT-backed angel networks on any cap table, confirming the post-cut investor map is forming fast in the £4m–£40m band. The gap is structural: 36.7% of university spinouts raised below £500,000 in 2025, a tier neither the SAIU nor the BBB direct mandate touches.